Protagonist Therapeutics Director Selick Sells $2.52 Million in Shares
Published on 3/27/2026
AI Summary
Selick, a director at Protagonist Therapeutics, has sold shares worth $2.52 million. This sale may influence investor sentiment and market perceptions of the company's future performance. Such insider selling can be interpreted as a signal concerning the company's direction and financial health. As of October 2023, details on the number of shares sold and the price per share were not disclosed.
